MedTrace Logo

Buspirone Plus Omeprazole for Functional Dyspepsia

NCT03444831 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2018-02-23

No results posted yet for this study

Summary

This study is a double-blinded Randomised clinical trial aim to compare buspirone plus omeprazole with placebo plus omeprazole.

Conditions

  • Dyspepsia

Interventions

DRUG

Buspirone

Buspirone 5mg used QID a day after meal plus 20mg omeprazole before breakfast.

DRUG

Placebo Oral Tablet

Buspirone placebo QID after meal plus 20mg omeprazole before breakfast.

Sponsors & Collaborators

  • Isfahan University of Medical Sciences

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-03-01
Primary Completion
2017-03-01
Completion
2017-04-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03444831 on ClinicalTrials.gov